Faithward Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Buy |
2,959
+350
| +13% | +$65K | 0.09% | 157 |
|
|
2025
Q1 | $547K | Sell |
2,609
-101
| -4% | -$21.2K | 0.1% | 146 |
|
|
2024
Q4 | $482K | Sell |
2,710
-65
| -2% | -$11.6K | 0.08% | 156 |
|
|
2024
Q3 | $548K | Sell |
2,775
-70
| -2% | -$13.8K | 0.1% | 156 |
|
|
2024
Q2 | $488K | Buy |
2,845
+70
| +3% | +$12K | 0.09% | 167 |
|
|
2024
Q1 | $505K | Buy |
+2,775
| New | +$505K | 0.09% | 152 |
|
|
2023
Q3 | – | Sell |
-2,030
| Closed | -$309K | – | 249 |
|
|
2023
Q2 | $309K | Buy |
2,030
+237
| +13% | +$36.1K | 0.07% | 137 |
|
|
2023
Q1 | $263K | Buy |
1,793
+380
| +27% | +$55.7K | 0.06% | 158 |
|
|
2022
Q4 | $228K | Buy |
+1,413
| New | +$228K | 0.05% | 136 |
|
|
2020
Q3 | – | Sell |
-3,234
| Closed | -$318K | – | 215 |
|
|
2020
Q2 | $318K | Sell |
3,234
-495
| -13% | -$48.7K | 0.08% | 102 |
|
|
2020
Q1 | $284K | Sell |
3,729
-1,109
| -23% | -$84.5K | 0.08% | 128 |
|
|
2019
Q4 | $428K | Sell |
4,838
-138,158
| -97% | -$12.2M | 0.1% | 105 |
|
|
2019
Q3 | $10.8M | Buy |
+142,996
| New | +$10.8M | 2.4% | 17 |
|